Walgreens Healthcare Clinics Prescribe Pre-Exposure Prophylaxis for HIV Prevention
PrEP has been found to be effective in preventing HIV in high-risk populations.
Providers at Walgreens Healthcare Clinics in 17 new markets can now prescribe pre-exposure prophylaxis (PrEP).
Following the initial PrEP consultation, clinic providers can test for HIV and other sexually transmitted infections (STIs), according to a press release. After reviewing the test results, providers will conduct a follow-up visit and may prescribe PrEP, as necessary.
PrEP is a daily medication designed to
“In late April, we began prescribing PrEP at our Walgreens Healthcare Clinic locations in the Houston area,” Pat Carroll, MD, chief medical officer for Walgreens Healthcare Clinics, said in a release. “Over the past few months, local AIDS organizations across the Houston area have referred patients to our clinics. In addition, our patients in Houston have commended us for giving them an easy option to learn more about PrEP and, if applicable, after a consultation, to get a prescription from one of our providers.”
Several Walgreens Healthcare Clinic locations also began offering evaluation and testing in late April for STIs, including HIV, hepatitis B and C virus, chlamydia, gonorrhea, as well as treatment and counseling and referral.
The new markets include Cincinnati; Cleveland; Columbus, OH; Dallas; Denver; Kansas City, Knoxville; Las Vegas; Louisville; Memphis; Nashville; Orlando; Philadelphia; Phoenix; Tucson; Washington, DC; and Wichita.
“As we continue to help improve the comprehensive health and wellbeing of our patients, while also supporting communities across the nation that are impacted by HIV, we are looking forward to rolling out our prevention initiative more broadly,” Dr Carroll said.
In the United States, an estimated 1.1 million individuals are living with HIV, with 1 of 7 unaware of their status, according to the release. Men who have sex with men (MSM) and bisexual men—–particularly young African Americans––have the
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
- Effectively Managing Immunizations in the Long-Term Care Setting
September 18th 2025
- Creating a Culture of Quality in Fast-Melt Tablet Development
September 18th 2025
- Advise Patients About Self-Care Measures to Treat Mild to Moderate GI Issues
September 18th 2025